Literature DB >> 24971714

Endogenous aryl hydrocarbon receptor promotes basal and inducible expression of tumor necrosis factor target genes in MCF-7 cancer cells.

Travis B Salisbury1, Justin K Tomblin2, Donald A Primerano3, Goran Boskovic4, Jun Fan5, Inderjit Mehmi6, Jackie Fletcher7, Nalini Santanam8, Estil Hurn9, Gary Z Morris10, James Denvir11.   

Abstract

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that upon activation by the toxicant 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD) stimulates gene expression and toxicity. AHR is also important for normal mouse physiology and may play a role in cancer progression in the absence of environmental toxicants. The objective of this report was to identify AHR-dependent genes (ADGs) whose expression is regulated by AHR in the absence of toxicants. RNA-Seq analysis revealed that AHR regulated the expression of over 600 genes at an FDR<10% in MCF-7 breast cancer cells upon knockdown with short interfering RNA. Pathway analysis revealed that a significant number of ADGs were components of TCDD and tumor necrosis factor (TNF) pathways. We also demonstrated that siRNA knockdown of AHR modulated TNF induction of MNSOD and cytotoxicity in MCF-7 cells. Collectively, the major new findings of this report are: (1) endogenous AHR promotes the expression of xenobiotic metabolizing enzymes even in the absence of toxicants and drugs, (2) AHR by modulating the basal expression of a large fraction of TNF target genes may prime them for TNF stimulation and (3) AHR is required for TNF induction of MNSOD and the cellular response to cytotoxicity in MCF-7 cells. This latter result provides a potentially new role for AHR in MCF-7 cancer progression as a mediator of TNF and antioxidant responses.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aryl hydrocarbon receptor (AHR); Breast cancer; Gene expression; Tumor necrosis factor; Xenobiotics

Mesh:

Substances:

Year:  2014        PMID: 24971714      PMCID: PMC4157967          DOI: 10.1016/j.bcp.2014.06.015

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  53 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  N J Walker; C J Portier; S F Lax; F G Crofts; Y Li; G W Lucier; T R Sutter
Journal:  Toxicol Appl Pharmacol       Date:  1999-02-01       Impact factor: 4.219

3.  Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Kah Poh Tan; Bernice Wang; Mingdong Yang; Paul C Boutros; Jane Macaulay; Haibo Xu; Andrew I Chuang; Kazuhiro Kosuge; Mika Yamamoto; Shinichiro Takahashi; Alex M L Wu; Douglas D Ross; Patricia A Harper; Shinya Ito
Journal:  Mol Pharmacol       Date:  2010-05-11       Impact factor: 4.436

4.  Liver deformation in Ahr-null mice: evidence for aberrant hepatic perfusion in early development.

Authors:  Eric B Harstad; Christopher A Guite; Tami L Thomae; Christopher A Bradfield
Journal:  Mol Pharmacol       Date:  2006-01-27       Impact factor: 4.436

Review 5.  A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family.

Authors:  Christoph F A Vogel; Fumio Matsumura
Journal:  Biochem Pharmacol       Date:  2008-10-08       Impact factor: 5.858

6.  The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells.

Authors:  Raymond Lo; Jason Matthews
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-11       Impact factor: 4.219

7.  The active form of human aryl hydrocarbon receptor (AHR) repressor lacks exon 8, and its Pro 185 and Ala 185 variants repress both AHR and hypoxia-inducible factor.

Authors:  Sibel I Karchner; Matthew J Jenny; Ann M Tarrant; Brad R Evans; Hyo Jin Kang; Insoo Bae; David H Sherr; Mark E Hahn
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

8.  Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands.

Authors:  Kaname Kawajiri; Yasuhito Kobayashi; Fumiaki Ohtake; Togo Ikuta; Yoshibumi Matsushima; Junsei Mimura; Sven Pettersson; Richard S Pollenz; Toshiyuki Sakaki; Takatsugu Hirokawa; Tetsu Akiyama; Masafumi Kurosumi; Lorenz Poellinger; Shigeaki Kato; Yoshiaki Fujii-Kuriyama
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

Review 9.  Lipoxygenase metabolism: roles in tumor progression and survival.

Authors:  Graham P Pidgeon; Joanne Lysaght; Sriram Krishnamoorthy; John V Reynolds; Ken O'Byrne; Daotai Nie; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

10.  Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line.

Authors:  Gennifer D Goode; Billy R Ballard; H Charles Manning; Michael L Freeman; Yibin Kang; Sakina E Eltom
Journal:  Int J Cancer       Date:  2013-07-05       Impact factor: 7.396

View more
  8 in total

1.  Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.

Authors:  Justin K Tomblin; Subha Arthur; Donald A Primerano; Ateeq R Chaudhry; Jun Fan; James Denvir; Travis B Salisbury
Journal:  Biochem Pharmacol       Date:  2016-03-02       Impact factor: 5.858

2.  Compendium of TCDD-mediated transcriptomic response datasets in mammalian model systems.

Authors:  Stephenie D Prokopec; Kathleen E Houlahan; Ren X Sun; John D Watson; Cindy Q Yao; Jamie Lee; Christine P'ng; Renee Pang; Alexander H Wu; Lauren C Chong; Ashley B Smith; Nicholas J Harding; Ivy D Moffat; Jere Lindén; Sanna Lensu; Allan B Okey; Raimo Pohjanvirta; Paul C Boutros
Journal:  BMC Genomics       Date:  2017-01-13       Impact factor: 3.969

3.  High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.

Authors:  Sophie Vacher; Patrice Castagnet; Walid Chemlali; François Lallemand; Didier Meseure; Marc Pocard; Ivan Bieche; Martine Perrot-Applanat
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

4.  AHR is a master regulator of diverse pathways in endogenous metabolism.

Authors:  Jeffry C Granados; Kian Falah; Imhoi Koo; Ethan W Morgan; Gary H Perdew; Andrew D Patterson; Neema Jamshidi; Sanjay K Nigam
Journal:  Sci Rep       Date:  2022-10-05       Impact factor: 4.996

Review 5.  The Aryl Hydrocarbon Receptor Relays Metabolic Signals to Promote Cellular Regeneration.

Authors:  Fanny L Casado
Journal:  Stem Cells Int       Date:  2016-08-03       Impact factor: 5.443

Review 6.  The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer.

Authors:  Travis B Salisbury; Subha Arthur
Journal:  Int J Mol Sci       Date:  2018-08-12       Impact factor: 5.923

7.  Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.

Authors:  Ming-Jun Shi; Xiang-Yu Meng; Jacqueline Fontugne; Chun-Long Chen; François Radvanyi; Isabelle Bernard-Pierrot
Journal:  Genome Med       Date:  2020-09-28       Impact factor: 11.117

8.  Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression.

Authors:  Benjamin Heng; Ayse A Bilgin; David B Lovejoy; Vanessa X Tan; Heloisa H Milioli; Laurence Gluch; Sonia Bustamante; Tharani Sabaretnam; Pablo Moscato; Chai K Lim; Gilles J Guillemin
Journal:  Breast Cancer Res       Date:  2020-10-27       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.